Unknown

Dataset Information

Effect of Sodium Benzoate vs Placebo Among Individuals With Early Psychosis: A Randomized Clinical Trial.


ABSTRACT:

Importance

There is evidence that sodium benzoate (BZ) may be an effective adjunctive treatment for schizophrenia. The clinical efficacy of BZ has been investigated in chronic schizophrenia; however, the efficacy of this agent has not been studied in individuals with early psychosis.

Objective

To examine the clinical efficacy of the adjunctive use of BZ for symptoms in people with early psychosis.

Design, setting, and participants

Using a placebo-controlled double-masked parallel-group design, this randomized clinical trial was conducted from August 2015 to July 2018. Participants aged between 15 and 45 years experiencing early psychosis were enrolled from 5 major clinical sites in Queensland, Australia. Data analysis was conducted from October 2018 to February 2020.<

SUBMITTER: Scott JG 

PROVIDER: S-EPMC7656289 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature